Dataset Information

Large-scale Identification and Time-course Quantification of Ubiquitylomes in De-etiolating Maize Seedling Leaf

ABSTRACT: Ubiquitylation is a widely known post-translational modification that regulates myriad biochemical and physiological events in organism. The ubiquitin system is crucial for the development and fitness of higher plants. The process of de-etiolation, during which green plants initiate photomorphogenesis and establish autotrophy, is a dramatic and complicated procedure under the tight regulation of massive ubiquitylation/de-ubiquitylation events. Here we present site-specifically quantified proteomic data of the ubiquitylomes in seedlings’ first leaves of a globally important crop and C4 model plant, Zea Mays, in etiolated state and early de-etiolating states (exposed to light for one, six and twelve hours, respectively), achieved through an immunoprecipitation-based high-resolution mass spectroscopic (MS) method. In our composite data of multiple ubiquitylomes, 1926 unique ubiquitylation sites corresponding to 1041 proteins were identified and quantified, based on which five potential ubiquitylation motifs, KA, AXK, KXG,AK and TK were found. The time-course fold change of the ubiquitylation levels of 214 sites corresponding to 172 proteins were detected to be highly correlated in two technical replicates of MS experiments; evident fold changes (>1.5 fold) of the ubiquitylation levels of 78 sites during the 12 hours’ de-etiolation process were detected. A majority of the ubiquitylated sites we identified corresponded to substrates involving protein and DNA metabolism, such as ribosome and histone; meanwhile, multiple ubiquitylation sites in proteins reflecting plant’s major physiological changes during de-etiolation, including hormone synthesis/signaling, key C4 photosynthetic enymes, light signaling proteins were identified. This proteomic study on the ubiquitylome of de-etiolating maize seedling leaf is the first attempt ever of studying the ubiquitylome of C4 plant.

INSTRUMENT(S): LTQ Orbitrap

ORGANISM(S): Zea Mays (maize)

TISSUE(S): Leaf

SUBMITTER: Tiancong Lu

LAB HEAD: Baichen Wang

PROVIDER: PXD007880 | Pride | 2020-04-09

REPOSITORIES: Pride

ACCESS DATA

Dataset's files

Source:

Items per page:

1 - 5 of 16

Publications

Large-scale Identification and Time-course Quantification of Ubiquitylation Events During Maize Seedling De-etiolation.

Wang Yue-Feng YF Chao Qing Q Li Zhe Z Lu Tian-Cong TC Zheng Hai-Yan HY Zhao Cai-Feng CF Shen Zhuo Z Li Xiao-Hui XH Wang Bai-Chen BC

Genomics, proteomics & bioinformatics 20191201 6

The ubiquitin system is crucial for the development and fitness of higher plants. De-etiolation, during which green plants initiate photomorphogenesis and establish autotrophy, is a dramatic and complicated process that is tightly regulated by a massive number of ubiquitylation/de-ubiquitylation events. Here we present site-specific quantitative proteomic data for the ubiquitylomes of de-etiolating seedling leaves of Zea mays L. (exposed to light for 1, 6, or 12 h) achieved through immunoprecipi ...[more]

PMID: 32179194

Similar Datasets

Project description:Lung cancer is the leading cause of cancer death. Mutations in the kinase domain of EGFR, a predominant driver oncogene, such as L858R missense mutation and a series of deletions spanning the conserved sequence 747LREA750, are associated with sensitivity to tyrosine kinase inhibitors (TKIs). However, patients receiving EGFR-TKIs (gefitinib and erlotinib) develop drug-resistance due to a secondary mutation at the gatekeeper residue (T790M) in about 50-60% of cases, urging for new drug development. Afatinib, a FDA approved second-generation EGFR-TKI that was developed to circumvent T790M-mediated resistance, has not been very effective in clinical trials. In this study, we performed a global phosphoproteomic screen to identify targets that undergo mutant EGFR-dependent tyrosine phosphorylation and their modulation by erlotinib or afatinib. We undertook stable isotope labeling of amino acids in cell culture (SILAC), phosphopeptide enrichment, and quantitative mass spectrometry to identify dynamic changes of phosphorylation downstream of mutant EGFRs in lung adenocarcinoma cells harboring L858R or L858R/T790M mutations and their modulation by erlotinib and afatinib inhibition. We identified and quantified 397, 429, 223, and 594 phosphotyrosine sites in H3255, 11-18,PC9, and H1975 cell lines that were grown in presence of FBS and in presence/absence of TKIs, respectively. These account for a total of 907 unique phospho-tyrosine sites in 496 proteins. Among them, 187 phosphotyrosine sites were found to be in 89 kinases, which may serve as intermediary regulatory kinases in EGFR signalling pathway. Further analysis indicated that in TKI-sensitive H3255 and 11-18 cells, there were 58/111 and 65/101 tyrosine sites that were hypophosphorylated in presence of erlotinib and afatinib, respectively. However, in TKI-resistant H1975 cells, 189 and 264 tyrosine sites were hypophosphorylated in presence of erlotinib and afatinib respectively, indicating that the afatinib-specific additional sites could be validated for identifying potentially new drug targets to counter TKI-resistance. Ingenuity pathway analysis (IPA) of proteins with altered phosphorylation sites demonstrated that several canonical pathways including ephrin receptor signalling and integrin signalling pathways were enriched, which may play important roles in cell growth and proliferation. However, upon EGF stimulation of serum starved H3255 cells in presence or absence of TKIs, 99 tyrosine sites that were hyperphosphorylated upon EGF stimulation were inhibited in presence of erlotinib or afatinib. But in H1975 cells treated with erlotinib, 48 of the above sites were either unchanged or were hyperphosphorylated. These sites include EGFR (Y1197/869/998), JAK1 (Y1034), FRK (Y497), GAB1 (Y657/689), MAPK1 (Y187), MAPK3 (Y204), MET (Y1252/1253). Furthermore, a total of 112 sites that were observed to be hypophosphorylated upon EGF stimulation in H1975 cells, were found to be hyperphosphorylated upon erlotinib inhibition. This could possibly be due to the activation of downstream phosphatases with EGF stimulation. We are now performing in-depth bioinformatic analysis and validation experiments using functional genomics to understand the role of targets of mutant EGFR signalling in lung cancer.

			Action	DRS
	VLS10057-2.raw	Raw
	VLS10058-1.raw	Raw
	VLS10058-2.raw	Raw
	VLS10059-1.raw	Raw
	VLS10059-2.raw	Raw